Effects of performance enhancing drugs on the health of athletes and athletic competition: hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Sixth Congress, first session, October 20, 1999, Volumes 73-77

Front Cover
U.S. G.P.O., 2002 - Medical - 116 pages
0 Reviews

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Hearing held October 20 1999
1
Coleman Doriane Lambelet Professor Duke University School of Law 85
12
Serota Scott Executive Vice President and chief operating officer Blue Cross
31

4 other sections not shown

Common terms and phrases

Bibliographic information